Centene Corporation (CNC)

NYSE · St. Louis, Missouri, USA · Founded 1984 · CEO Sarah London

Valuation summary

$233.97 fair value versus $65.58 in the market, a difference of +256.8%. Rated Strong Buy.

Fair value per share$233.97
Current share price$65.58
Upside / downside+256.8%
Bear case$47.01
Bull case$537.57
Discount rate (WACC)9.9%
Terminal growth2.40%
Market capitalisation$32B
EV / Sales0.1x

About Centene Corporation

Founded in 1984 by Elizabeth Brinn as a single Wisconsin health plan. Sarah London has been CEO since 2022. Centene is the largest US Medicaid managed care organisation, administering government health programmes for low-income populations across most states, plus a substantial marketplace insurance business. Revenue depends almost entirely on government contracts and reimbursement rates.

Investment case

  • Scale leader in Medicaid managed care, an area states continue to outsource.
  • Marketplace enrolment has grown substantially with enhanced subsidies.
  • Trades at a low multiple relative to the broader managed care group.

Key risks

  • Medicaid redeterminations left a sicker remaining membership, pressuring margins badly.
  • State reimbursement rates have lagged actual medical cost trends.
  • Expiry of enhanced marketplace subsidies is a direct and dated risk to enrolment.

Recent developments

Revenue by segment

Medicaid55%
Marketplace25%
Medicare12%
Other8%

Five-year forecast

RevenueFree cash flow
Year 1$231.6B$4.3B
Year 2$266.6B$5.3B
Year 3$301.8B$6.3B
Year 4$335.8B$7.5B
Year 5$367.3B$8.6B

What the street says

One of the most contested managed care names. Rate adequacy versus medical costs drives everything.

Comparable companies: HUM · DXCM · CAH · NTRA · MCK · MDLN · COR · RMD

Open the interactive model, price chart and sensitivity grid →